Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Malaria, Plasmodium Falciparum”

Showing 20 of 0 results

Early research (Phase 1)Ended earlyNCT02543086
What this trial is testing

Effectiveness of KAE609 in Reducing Asexual & Sexual Blood-stage P.Falciparum Infection & Infectivity to Mosquitos

Who this might be right for
Plasmodium Falciparum Malaria
Novartis Pharmaceuticals 8
Early research (Phase 1)Not Yet RecruitingNCT07730177
What this trial is testing

Challenge Trial of PfSPZ-LARC2 Vaccine in Burkina Faso

Who this might be right for
Malaria (Plasmodium Falciparum)
Sanaria Inc. 45
Testing effectiveness (Phase 2)Study completedNCT01623557
What this trial is testing

A Challenge Study to Assess the Protective Efficacy of Two Malaria Vaccine Candidates

Who this might be right for
Plasmodium Falciparum Malaria
University of Oxford 30
Large-scale testing (Phase 3)Study completedNCT00371735
What this trial is testing

Chlorproguanil-Dapsone-Artesunate (CDA) Versus Chlorproguanil-Dapsone (LAPDAP) For Uncomplicated Malaria

Who this might be right for
Malaria, Falciparum
GlaxoSmithKline 900
Not applicableNot Yet RecruitingNCT07773350
What this trial is testing

Insecticide-Treated Baby Wraps for the Prevention of Malaria

Who this might be right for
Malaria (Plasmodium Falciparum)Malaria Incidence
University of North Carolina, Chapel Hill 1,296
Early research (Phase 1)Study completedNCT02942277
What this trial is testing

Safety and Immunogenicity of Pfs25M-EPA/AS01 and Pfs230D1M-EPA/AS01 Vaccines, Transmission Blocking Vaccines Against Plasmodium Falciparum, at Full and Fractional Dosing in Adults in Mali

Who this might be right for
Malaria
National Institute of Allergy and Infectious Diseases (NIAID) 301
Large-scale testing (Phase 3)Study completedNCT00422084
What this trial is testing

Pyronaridine Artesunate (3:1) Versus Coartem® in P Falciparum Malaria Patients

Who this might be right for
Malaria
Medicines for Malaria Venture 1,272
Large-scale testing (Phase 3)UnknownNCT04149106
What this trial is testing

Seasonal Malaria Chemoprevention With Dihydroartemisin Piperaquin vs. Sulfadoxine-pyrimethamin+Amodiaquin

Who this might be right for
Malaria,Falciparum
University Clinical Research Center, Mali 4,556
Testing effectiveness (Phase 2)Ended earlyNCT00082563
What this trial is testing

Azithromycin in Combination With Chloroquine Versus Chloroquine in the Eradication of Asymptomatic Plasmodium Falciparum

Who this might be right for
Malaria, Falciparum
Pfizer 14
Post-approval studies (Phase 4)UnknownNCT00902811
What this trial is testing

Effectiveness of Artemisinin Combination Regimens in Falciparum Malaria

Who this might be right for
Uncomplicated Falciparum Malaria
Medecins Sans Frontieres, Netherlands 600
Not applicableStudy completedNCT00314899
What this trial is testing

Fetal Immunity to Falciparum Malaria

Who this might be right for
Plasmodium Falciparum Malaria
National Institute of Allergy and Infectious Diseases (NIAID) 500
Early research (Phase 1)Study completedNCT02181088
What this trial is testing

A Phase Ia Clinical Trial to Assess the Safety and Immunogenicity of New Plasmodium Falciparum Malaria Vaccine Candidates ChAd63 RH5 Alone and With MVA RH5

Who this might be right for
MalariaPlasmodium Falciparum
University of Oxford 26
Post-approval studies (Phase 4)Study completedNCT00454961
What this trial is testing

Effectiveness of Artemether-Lumefantrine for Malaria Treatment of Children at Community Level in Tanzania

Who this might be right for
Malaria
Karolinska University Hospital 200
Not applicableStudy completedNCT00338520
What this trial is testing

Hyperphenylalaninemia in Cerebral Malaria

Who this might be right for
Plasmodium Falciparum Malaria
University of Utah 285
Early research (Phase 1)Study completedNCT00730782
What this trial is testing

Assessment of Three Formulations of the Candidate Vaccine AMA 1 in Healthy Dutch Adult Volunteers

Who this might be right for
Plasmodium Falciparum Malaria
European Vaccine Initiative 56
Early research (Phase 1)Study completedNCT00666380
What this trial is testing

Determine the Effects of an Investigational Malaria Vaccine Given to Adults Living in the United States and Thereafter to Adults Living in Kenya

Who this might be right for
Malaria
U.S. Army Medical Research and Development Command 26
Large-scale testing (Phase 3)Study completedNCT01935882
What this trial is testing

Low Dose Primaquine for Clearance of Gametocytes

Who this might be right for
MalariaAsymptomatic MalariaPlasmodium Falciparum
London School of Hygiene and Tropical Medicine 360
Early research (Phase 1)Study completedNCT05581641
What this trial is testing

Safety and Immune Responses After Vaccination With an Investigational RNA-based Vaccine Against Malaria

Who this might be right for
Malaria
BioNTech SE 60
Testing effectiveness (Phase 2)Looking for participantsNCT05790889
What this trial is testing

Test Experimental Blood Stage Malaria Vaccine in Burkina Faso.

Who this might be right for
Malaria,Falciparum
University of Oxford 480
Post-approval studies (Phase 4)Ended earlyNCT00386750
What this trial is testing

Safety of Artemether - Lumefantrine, and Other Malaria Drugs and Their Effect on the Auditory Function

Who this might be right for
MalariaFalciparum
Novartis Pharmaceuticals 265
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation